Top 5 Blue Chip Stocks For 2019

Malaysia’s stock benchmark slid for a fourth day, erasing its advance for 2018, after the government said national debt was higher than previously disclosed due to some masking of accounts by the previous administration.

The FTSE Bursa Malaysia KLCI Index fell 1.4 percent to 1,778.41, the lowest since Dec. 27, as of 10:33 a.m. in Kuala Lumpur. It had slumped as much as 2 percent. The benchmark lost gains of as much as 5.5 percent this year, as bank shares led Thursday’s decline.

"People are selling first and asking questions later," said Clive McDonnell, the Singapore-based head of emerging market equity strategy at Standard Chartered Bank. "I don’t think that’s a surprise to see those outflows given the uncertainty until there’s greater clarity on economic management going forward."

#lazy-img-328011050:before{padding-top:56.25%;}

There was sudden panic selling, said Ang Kok Heng, chief investment officer at Phillip Capital Management Sdn. in Kuala Lumpur. Still, "we are accumulating selected blue chips as these have been battered. The outlook of the economy would be better with good corporate governance and a government that is more efficient and fair."

Top 5 Blue Chip Stocks For 2019: Daiichi Sankyo Company, Limited (DSKYF)

Advisors’ Opinion:

  • [By ]

    Daiichi Sankyo (OTCPK:DSKYF)

    There are 4 members of the EGF receptor family, but in cancer research we tend to focus mainly on the first two: EGFR and HER2. But we are also gaining a better understanding of the third family member, HER3, which is an odd duck because of its willingness to form dimers not with itself, but with other members of the EGFR family. And it is highly active in PI3K/Akt signaling, as well. So it’s no surprise that companies are trying to exploit this receptor as a therapeutic target. DSKYF’s U3-1402 is an antibody-drug conjugate targeting HER3 and delivering a lethal payload to tumor cells. This phase 1/2 study focused on the use of this agent in metastatic breast cancer overexpressing HER3.

Top 5 Blue Chip Stocks For 2019: MDC Partners Inc.(MDCA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news stories that may have effected Accern’s analysis:

    Get MDC Partners alerts:

    $0.09 Earnings Per Share Expected for MDC Partners Inc (MDCA) This Quarter (americanbankingnews.com) Head-To-Head Review: MDC Partners (MDCA) vs. HAVAS (HAVSF) (americanbankingnews.com) Telaria (TLRA) & MDC Partners (MDCA) Head to Head Survey (americanbankingnews.com) Comparing WPP (WPP) & MDC Partners (MDCA) (americanbankingnews.com)

    Shares of MDC Partners traded up $0.15, reaching $4.80, during midday trading on Monday, according to Marketbeat.com. 391,100 shares of the company were exchanged, compared to its average volume of 478,690. The stock has a market cap of $278.13 million, a PE ratio of 7.87, a P/E/G ratio of 1.99 and a beta of 1.13. MDC Partners has a 1-year low of $3.80 and a 1-year high of $12.26. The company has a debt-to-equity ratio of -3.37, a current ratio of 0.74 and a quick ratio of 0.74.

  • [By Lisa Levin]

    Shares of MDC Partners Inc. (NASDAQ: MDCA) were down 33 percent to $ 4.575 after a first-quarter earnings miss.

    Hudson Technologies Inc. (NASDAQ: HDSN) was down, falling around 32 percent to $2.7799 after the company reported downbeat Q1 earnings.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    MDC Partners Inc. (NASDAQ: MDCA) fell 23.4 percent to $5.25 in pre-market trading after a first-quarter earnings miss.
    Hudson Technologies Inc. (NASDAQ: HDSN) shares fell 15.1 percent to $3.48 in pre-market trading after the company reported downbeat Q1 earnings.
    Nuance Communications, Inc. (NASDAQ: NUAN) fell 14 percent to $13.15 in pre-market trading after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
    Myomo, Inc. (NYSE: MYO) fell 13.2 percent to $3.10 in pre-market trading after reporting downbeat quarterly results.
    Rowan Companies plc (NYSE: RDC) shares fell 10.7 percent to $14.13 in pre-market trading after climbing 8.50 percent on Wednesday.
    BT Group plc (NYSE: BT) fell 9 percent to $14.80 in pre-market trading after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
    Exelixis, Inc. (NASDAQ: EXEL) fell 8.3 percent to $19.90 in pre-market trading after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
    Infinera Corporation (NASDAQ: INFN) fell 8.2 percent to $10.80 in pre-market trading after reporting Q1 results.
    Synaptics, Incorporated (NASDAQ: SYNA) shares fell 7.4 percent to $43.00 in pre-market trading. Synaptics reported better-than-expected earnings for its third quarter, while sales missed estimates.
    Randgold Resources Limited (NASDAQ: GOLD) shares fell 7.4 percent to $76.23 in pre-market trading after reporting Q1 earnings.
    Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares fell 7 percent to $59.36 in pre-market trading. Integra LifeSciences priced its 5.25 million share public offering of common stock at $58.50 per share.
    Array BioPharma Inc. (NASDAQ: ARRY) shares fell 6.9 percent to $12.75 in pre-m

Top 5 Blue Chip Stocks For 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Shane Hupp]

    HC Wainwright set a $5.00 price objective on Antares Pharma (NASDAQ:ATRS) in a research report released on Friday. The brokerage currently has a buy rating on the specialty pharmaceutical company’s stock.

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Top 5 Blue Chip Stocks For 2019: PIMCO California Municipal Income Fund III(PZC)

Advisors’ Opinion:

  • [By Max Byerly]

    PZ Cussons (LON:PZC) had its price objective decreased by Numis Securities from GBX 255 ($3.40) to GBX 230 ($3.06) in a research note issued to investors on Thursday. Numis Securities currently has a hold rating on the stock.

  • [By Ethan Ryder]

    Headlines about Pimco CA Muni. Income Fund III (NYSE:PZC) have trended somewhat positive recently, Accern reports. The research group scores the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pimco CA Muni. Income Fund III earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news headlines about the investment management company an impact score of 48.0089575306336 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Top 5 Blue Chip Stocks For 2019: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By Shane Hupp]

    NN Investment Partners Holdings N.V. increased its holdings in Prudential Financial Inc (NYSE:PRU) by 0.1% during the 2nd quarter, Holdings Channel reports. The firm owned 2,197,076 shares of the financial services provider’s stock after buying an additional 2,780 shares during the period. Prudential Financial accounts for approximately 1.5% of NN Investment Partners Holdings N.V.’s portfolio, making the stock its 10th largest position. NN Investment Partners Holdings N.V.’s holdings in Prudential Financial were worth $205,450,000 at the end of the most recent reporting period.

  • [By Zacks]

    Well, given the growing demand for securitized mortgage deals, Barclays plans to package and sell these Irish loans over the next two months. The group of investors that has shown interest in buying residential mortgage backed securities includes M&G Investments, the investment management division of British insurer Prudential Plc (NYSE: PRU) and Pacific Investment Management Co. ("PIMCO").

  • [By Logan Wallace]

    KBC Group NV trimmed its holdings in shares of Prudential Financial Inc (NYSE:PRU) by 11.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 260,023 shares of the financial services provider’s stock after selling 35,173 shares during the period. KBC Group NV owned about 0.06% of Prudential Financial worth $24,315,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Wesbanco Bank Inc. raised its stake in Prudential Financial Inc (NYSE:PRU) by 5.9% during the second quarter, HoldingsChannel reports. The institutional investor owned 65,335 shares of the financial services provider’s stock after acquiring an additional 3,655 shares during the period. Wesbanco Bank Inc.’s holdings in Prudential Financial were worth $6,110,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Prudential (LON:PRU) had its target price hoisted by Berenberg Bank from GBX 2,400 ($30.96) to GBX 2,600 ($33.54) in a research note published on Thursday morning, Marketbeat.com reports. They currently have a buy rating on the financial services provider’s stock.

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) takes such pride in its rock-solid financial condition that it uses an actual rock — the Rock of Gibraltar — as its corporate symbol. Prudential Financial backs up that claim with a balance sheet that has more cash, cash equivalents, and short-term investments than total debt on it. It also claims a debt-to-equity ratio around 0.6 and a current ratio around 1.0 , which are further signs of a solid financial condition.

Leave a Reply

Your email address will not be published. Required fields are marked *